Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation.
about
Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaEffect of APE1 and XRCC1 gene polymorphism on susceptibility to hepatocellular carcinoma and sensitivity to cisplatinElevated CXCL1 increases hepatocellular carcinoma aggressiveness and is inhibited by miRNA-200aGlypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.Prognostic significance of glypican-3 expression in hepatocellular carcinoma: A meta-analysis.
P2860
Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic value of glypican-3 ...... a after liver transplantation.
@en
type
label
Prognostic value of glypican-3 ...... a after liver transplantation.
@en
prefLabel
Prognostic value of glypican-3 ...... a after liver transplantation.
@en
P2093
P1476
Prognostic value of glypican-3 ...... a after liver transplantation.
@en
P2093
P304
P356
10.1016/S1499-3872(15)60349-6
P577
2015-04-01T00:00:00Z